Published by Iain Gilbert on 2nd February 2026
(Sharecast News) - Drugmaker Astrazeneca said on Monday that its gastric and gastroesophageal junction cancer treatment, Imfinzi, has been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use (CHMP).
URL: http://www.digitallook.com/dl/news/story/35669064/...